CORRECTION OF IMMATERIAL ERRORS (Narrative) (Details) - USD ($) |
3 Months Ended | 6 Months Ended | 9 Months Ended | 12 Months Ended | |||||
|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2026 |
Sep. 30, 2025 |
Jun. 30, 2025 |
Mar. 31, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Sep. 30, 2025 |
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Error Corrections and Prior Period Adjustments Restatement [Line Items] | |||||||||
| Grant income | $ 163,723 | $ 0 | |||||||
| Business development | $ 102,089 | $ 582,125 | $ 246,104 | $ 762,125 | 1,841,982 | 360,000 | |||
| Accounts payable and accrued liabilities | 1,436,358 | 1,436,358 | 966,088 | 731,756 | |||||
| Consulting fees | 4,263,195 | 998,364 | |||||||
| Prepaid expenses | 230,688 | 134,572 | |||||||
| Research and development expenses | 1,918 | 186,513 | 85,181 | 441,992 | 1,027,203 | 0 | |||
| Net loss | $ 11,458,207 | $ 1,934,427 | $ 15,727,338 | $ 4,587,534 | $ 16,543,616 | $ 7,908,777 | |||
| Loss per share | $ 0.24 | $ 0.09 | $ 0.35 | $ 0.23 | $ 0.76 | $ 0.46 | |||
| Adjustment [Member] | |||||||||
| Error Corrections and Prior Period Adjustments Restatement [Line Items] | |||||||||
| Research and development expenses | $ 255,479 | ||||||||
| As corrected [Member] | |||||||||
| Error Corrections and Prior Period Adjustments Restatement [Line Items] | |||||||||
| Business development | $ 472,500 | $ 376,125 | $ 376,125 | $ 848,625 | |||||
| Accounts payable and accrued liabilities | 848,625 | 376,125 | 376,125 | 848,625 | |||||
| Consulting fees | 100,000 | 100,000 | |||||||
| Prepaid expenses | 100,000 | 100,000 | |||||||
| Research and development expenses | 255,479 | 255,479 | |||||||
| Net loss | $ 2,422,410 | $ 1,934,427 | $ 2,653,107 | $ 4,587,534 | $ 7,009,944 | ||||
| Loss per share | $ 0.12 | $ 0.09 | $ 0.13 | $ 0.23 | $ 0.34 | ||||
| X | ||||||||||
- Definition The amount represents for grant income. No definition available.
|
| X | ||||||||||
- Definition Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Business development involves the development of products and services, their delivery, design and their implementation. Business development includes a number of techniques designed to grow an economic enterprise. Such techniques include, but are not limited to, assessments of marketing opportunities and target markets, intelligence gathering on customers and competitors, generating leads for possible sales, follow-up sales activity, formal proposal writing and business model design. Business development involves evaluating a business and then realizing its full potential, using such tools as marketing, sales, information management and customer service. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense for professional and contracted services. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|